美股A股
StockGist

IM Cannabis Corp.

IMCCNASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic
IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel, Germany, and Canada.
$0.64+7.52%
报价 2026-11-06
市值
$385,302
EV
–
PE (TTM)
–
预期 PE
–
52 周区间距高点 -98.9%
$0.59$56.40

筛选结果

pipeline · 2026-11-06
Filter✗ 高增长✗ Cheap✗ GARP
market cap below $300M floor

研究结论

还没有研究记录。先生成 L2 基本面报告(约 1–3 分钟),结论会显示在这里。

去生成基本面报告 →

历史股价

加载中…

事件

0 条 · 随区间与图例筛选

该区间内无事件。

同行对比

同行业市值相近 · Drug Manufacturers - Specialty & Generic
公司市值今日预期营收增速毛利率PEEV/EBITDAP/FCF池
IMCCIM Cannabis Corp.$385,302+7.5%–19.8%–47.8x4.3x
SNOASonoma Pharmaceuticals, Inc.$5.3M+3.7%+15.5%38.9%–––
YCBDcbdMD, Inc.$4.7M+7.2%+7.1%54.7%–––
APUSApimeds Pharmaceuticals US, Inc$4.1M-0.9%–0%–––
GELSGelteq Limited Ordinary Shares$4M-3.4%–100%–––
AKANAkanda Corp.$2M-1.4%–-160.1%–––
RDHLRedHill Biopharma Ltd.$1.3M+0.4%–100%–––
UPCUniverse Pharmaceuticals Inc.$878,148-0.7%–35.9%–––
PRFXPRF Technologies Ltd.$70,135+14.8%–-307.6%–––
同行中位数––+11.3%37.4%–––

研究全文

L2 基本面 memo

尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。

财务报表

报告货币 CAD(非美元)
Metric
2026-06-30
Q2 2026
2026-03-31
Q1 2026
2025-12-31
Q4 2025
2025-09-30
Q3 2025
2025-06-30
Q2 2025
2025-03-31
Q1 2025
2024-12-31
Q4 2024
2024-09-30
Q3 2024
RevenueCAD 7.6MCAD 8.7MCAD 11.2MCAD 13.9MCAD 12.7MCAD 12.5MCAD 13.3MCAD 13.9M
Gross Margin19.8%16.3%0.5%19.7%27%27.6%20.1%22.7%
Operating Margin-27.5%-19.3%-25.1%-30%-2.8%1.3%-147.6%6.9%
Net IncomeCAD -4.4MCAD -2.3MCAD -5.5MCAD -3.7MCAD -309,000CAD 275,000CAD -1MCAD -922,000
Diluted EPS-0.47-11.40-22.5-2.72.70-12.3
Operating Cash FlowCAD -1.3MCAD -186,000CAD 2.6MCAD -3.5MCAD -447,950CAD 4.5MCAD -4.2MCAD 2.8M

研究材料